Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A phase 3 trial of Cediranib in Glioma & glioblastoma, run by AstraZeneca, completed.
Overview
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma is a phase 3 interventional study registered as NCT00777153 by AstraZeneca, with 423 participants recorded, started 2008-10 and reaching its primary completion in 2010-04. Interventions recorded: Cediranib, Cediranib, Lomustine Chemotherapy, Placebo Cediranib. Conditions recorded: Recurrent Glioblastoma.
Linked to the drug Cediranib because the registry names it among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialAn RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
Shares Cediranib and the tag pipeline.
- TrialInjection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Study of BL-B01D1 in Patients With Recurrent Glioblastoma
Shares Glioma & glioblastoma and the tag pipeline.
- TrialCediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
Shares Cediranib and the tag pipeline.